Piperazine-derived ionizable lipids for enhanced mRNA delivery and cancer immunotherapy
- 30 May 2024
- journal article
- research article
- Published by Tsinghua University Press in Nano Research
- Vol. 17 (8) , 7357-7364
Abstract
Messenger ribonucleic acid (mRNA)-based therapeutics hold great prospects in disease treatment and lipid nanoparticles (LNPs) are the most extensively applied non-viral platform for RNA delivery in clinics. Despite the clinical success of LNPs as vehicles have been achieved, developing LNPs with enhanced mRNA transmembrane delivery and transfection efficiency in a non-toxic manner is highly desirable and challenging. In this study, we designed a series of new ionizable amino lipids with piperazine-derived headgroups and constructed a group of LNPs to promote the transfection activity of mRNA cargos. Among them, LNP formulated with lipid 10 (L10-LNP) can efficiently package mRNA and perform superior transfection efficiency both in vitro and in vivo, which is mainly attributed to the improved intracellular uptake and effective endosomal escape. We verified that a single administration of L10-LNP packaging interleukin (IL)-12 mRNA induced tumor shrink and even regression by robust activation of immune effector CD8+ T cells and stimulating the generation of IFN-γ without causing systemic toxicity, which provides a promising platform for clinical cancer immunotherapy.Keywords
This publication has 43 references indexed in Scilit:
- Development of a microchip capillary electrophoresis method for determination of the purity and integrity of mRNA in lipid nanoparticle vaccinesElectrophoresis, 2021
- Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugsDrug Metabolism and Pharmacokinetics, 2021
- mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stabilityInternational Journal of Pharmaceutics, 2021
- A Combinatorial Library of Lipid Nanoparticles for RNA Delivery to LeukocytesAdvanced Materials, 2020
- Patisiran Pharmacokinetics, Pharmacodynamics, and Exposure‐Response Analyses in the Phase 3 APOLLO Trial in Patients With Hereditary Transthyretin‐Mediated (hATTR) AmyloidosisThe Journal of Clinical Pharmacology, 2019
- Lipopolyplex potentiates anti-tumor immunity of mRNA-based vaccinationBiomaterials, 2017
- Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**Angewandte Chemie International Edition, 2012
- Safe and Effective Permeation Enhancers for Oral Drug DeliveryPharmaceutical Research, 2007
- Toxicity of cationic lipids and cationic polymers in gene deliveryJournal of Controlled Release, 2006
- Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acidsJournal of Controlled Release, 2005